Know Cancer

or
forgot password


N/A
N/A
N/A
Open (Enrolling)
Both
Ewing's Sarcoma

Thank you

Trial Information


Inclusion Criteria:



- Patients with Ewing's Sarcoma

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Efficacy

Outcome Time Frame:

overall

Safety Issue:

No

Principal Investigator

Muhammad Memon, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

Authority:

United States: Institutional Review Board

Study ID:

RAC#2031-065

NCT ID:

NCT00541411

Start Date:

June 2003

Completion Date:

June 2013

Related Keywords:

  • Ewing's Sarcoma
  • Sarcoma, Ewing's
  • Neuroectodermal Tumors, Primitive, Peripheral
  • Sarcoma

Name

Location